FIELD: molecular biology; medicine.
SUBSTANCE: invention refers to molecular biology and medicine and concerns a diagnostic technique for EBV-associated infectious mononucleosis. In peripheral leukocytes of patients with EBV-associated infectious mononucleosis, mRNA expression is detected SF1.NM_201995, XIAP.NM_001167 and genes BCL2L11, BIRC3, CELF6 and with reduced level of mRNA expression SF1.NM_201995, XIAP.NM_001167 and genes BCL2L11, BIRC3 on the background of increased expression level of CELF6 gene severe disease is diagnosed.
EFFECT: using the given method enables using the molecular-genetic markers to diagnose the severe EBV-IM course.
1 cl, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOMARKERS OF DEVELOPING COMPLICATIONS OF INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2720110C1 |
| METHOD FOR IDENTIFYING INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2732813C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF INFECTIOUS MONONUCLEOSIS OF VARIOUS AETIOLOGY | 2019 |
|
RU2707077C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF HERPES VIRUS MIXED INFECTION | 2020 |
|
RU2739854C1 |
| METHOD FOR PREDICTION OF SEVERITY OF EBV-ASSOCIATED INFECTIOUS MONONUCLEOSIS | 2020 |
|
RU2732010C1 |
| METHOD FOR DETECTION OF GENOTYPES 1 AND 2 OF EPSTEIN-BARR VIRUS | 2022 |
|
RU2789353C1 |
| METHOD FOR SIMULTANEOUS DETECTION OF LYMPHOTROPIC HERPESVIRUSES HHV6A, HHV6B, EBV AND ITS MAIN GENOTYPES EBV-1 AND EBV-2 | 2023 |
|
RU2805956C1 |
| METHOD FOR IDENTIFYING INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH TYPE 6 HUMAN HERPES VIRUS | 2019 |
|
RU2729413C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING WEB-ASSOCIATED TUMORS IN THE PATIENTS WITH ACUTE EBV-INFECTION | 2019 |
|
RU2707075C1 |
| METHOD OF PREDICTING RELAPSE OF EPSTEIN-BARR VIRAL INFECTION IN CHILDREN | 2023 |
|
RU2820959C1 |
